Histogen Inc
General ticker "HSTO" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $216.7K
Histogen Inc does not follow the US Stock Market performance with the rate: -33.5%.
Estimated limits based on current volatility of 0.5%: low 0.03$, high 0.03$
Factors to consider:
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2022-12-31 to 2024-12-30
- 2022-12-31 to 2023-12-31 estimated range: [0.64$, 1.98$]
- 2023-12-31 to 2024-12-30 estimated range: [0.63$, 1.74$]
Financial Metrics affecting the HSTO estimates:
- Negative: Non-GAAP EPS, $ of -3.37 <= 0.10
- Negative: Operating profit margin, % of -73.85 <= 1.03
- Negative: Operating cash flow per share per price, % of -75.12 <= 2.35
- Negative: negative Net income
Short-term HSTO quotes
Long-term HSTO plot with estimates
Financial data
| YTD | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|
| Operating Revenue | $2.06MM | $1.03MM | $3.77MM |
| Operating Expenses | $20.92MM | $16.49MM | $14.41MM |
| Operating Income | $-18.86MM | $-15.46MM | $-10.64MM |
| Non-Operating Income | $0.04MM | $0.45MM | $-0.00MM |
| Interest Expense | $0.06MM | $0.01MM | $0.00MM |
| R&D Expense | $6.22MM | $8.47MM | $5.02MM |
| Income(Loss) | $-18.82MM | $-15.01MM | $-10.64MM |
| Profit(Loss) | $-18.82MM | $-15.01MM | $-10.64MM |
| Stockholders Equity | $7.86MM | $21.19MM | $14.40MM |
| Inventory | $0.30MM | $1.73MM | $0.00MM |
| Assets | $15.01MM | $27.25MM | $19.07MM |
| Operating Cash Flow | $-12.05MM | $-14.53MM | $-9.68MM |
| Capital expenditure | $0.05MM | $0.24MM | $0.22MM |
| Investing Cash Flow | $10.97MM | $-0.24MM | $-0.22MM |
| Financing Cash Flow | $5.78MM | $27.09MM | $3.32MM |
| Earnings Per Share* | $-57.16 | $-7.51 | $-3.46 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.